Skip Navigation

A Phase III, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator?s Choice in Participants with Chemotherapy-na�ve Metastatic Castration-resistant Prostate Cancer

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT07213674

Study #:
STUDY00162133

Start Date:
Apr 22, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT07213674

View Complete Trial Details & Eligibility at ClinicalTrials.gov